Stock research
Healthcare · Life Sciences Tools & Services
Basis: Adjusted daily closes.
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.
Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies